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A B S T R A C T
Purpose
To establish the prevalence and determinants of poor social outcomes after a diagnosis of
colorectal cancer (CRC).
Patients and Methods
All 12- to 36-month survivors of CRC (International Classification of Diseases [10th revision] codes
C18 to C20) diagnosed in 2010 or 2011 and treated in the English National Health Service were
identified and sent a questionnaire from their treating cancer hospital. This included the Social
Difficulties Inventory, a 16-item scale of social distress (SD) comprising everyday living, money
matters, and self and others subscales, plus five single items. Sociodemographic and clinical data
were also collected. Analyses using descriptive statistics, 2 tests, and logistic regression models
were conducted.
Results
Response rate was 63.3% (21,802 of 34,467). Of the 21,802 participants, 17,830 (81.8%)
completed all SD items; 2,688 (15.1%) of these 17,830 respondents were classified as experi-
encing SD (everyday living, 19.5%; money matters, 15.6%; self and others, 18.1%). Multivariable
analysis demonstrated having  three long-term conditions was the strongest predictor of SD
(odds ratio [OR], 6.64; 95% CI, 5.67 to 7.77 compared with no long-term conditions), followed by
unemployment (OR, 5.11; 95% CI, 4.21 to 6.20 compared with being employed), having recurrent
or nontreatable disease (OR, 2.75; 95% CI, 2.49 to 3.04 compared with being in remission), and
having a stoma (OR, 2.10; 95% CI, 1.86 to 2.36 compared with no stoma). Additional predictors
of SD were young age ( 55 years), living in a more deprived area, nonwhite ethnicity, having
advanced-stage disease, having undergone radiotherapy, and being a carer.
Conclusion
Although it is reassuring a majority do not experience social difficulties, a minority reported
significant SD 12 to 36 months after diagnosis of CRC. The identified clinical and social risk factors
are easy to establish and should be used to target support.
J Clin Oncol 33:3423-3430. © 2015 by American Society of Clinical Oncology
INTRODUCTION
Improvements in survival and a slight rise in inci-
dence have resulted in an increase in the number of
people living with and beyond a diagnosis of colo-
rectal cancer (CRC).1,2 Most patients report good
health-related quality of life (QOL) in the years after
treatment, but some fare less well, especially those
with comorbidity.3-6 One study reported high over-
all QOL, with relatively good physical functioning,
but poor social and emotional outcomes compared
with the general population in 307 survivors ofCRC
at 12 and 36months postdiagnosis.3 This has impli-
cations for howhealth and social care providersmay
best identify those in need of support or rehabilita-
tion after primary cancer treatment.
To date, large-scale surveys of patients with
cancer have included QOL instruments measuring
psychological distress andunmet needs. The impor-
tance of social impacts is recognized as the number
of people reintegrating into everyday life with reha-
bilitationneeds increases,butmeasurementof social
impacts has been neglected.7 A number of instru-
ments covering a range of social impacts have been
developed over the last decade.8 The Social Difficul-
ties Inventory (SDI-21) specifically assesses difficul-
ties patients with cancer may experience with
everyday issues involving home and work, finances
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and relationships, and recreation.9 It has beenused to collect informa-
tion on problems experienced by individuals living with and be-
yond cancer.10-13
This study reports the findings of the SDI-21 in a survey of all
individuals alive 12 to 36 months after a CRC diagnosis in England.
The primary aims were to establish the prevalence and determinants
ofpoor socialoutcomesafterCRCandidentify factors that canbeused
to support targeted delivery of social support.
PATIENTS AND METHODS
Study Design
The study design has been described in detail elsewhere.10 Briefly, ap-
proval was given to approach patients without informed consent by the Na-
tional Information Governance Board (reference No. ECC 5-02[FT8]/12),
and research ethical approval on the survey data captured was granted by the
East of ScotlandResearchEthicsCommittee (referenceNo. 08/S0501/66).The
National Cancer Registration Service identified all individuals age 16 years
who had survived 1 to 3 years from a diagnosis of CRC (International Classi-
ficationofDiseases [10th revision]codesC18 toC20) in2010or2011andwere
treated in the National Health Service in England. Identified individuals
were sent a standard letter from their cancer center and a questionnaire
(Data Supplement). Two reminders were sent to nonresponders. The
questionnaire included a validated measure of social problems in cancer
patients (ie, SDI-21).9
Data Handling
Age categories ( 55, 55 to 64, 65 to 74, 75 to 84, and 85 years), sex,
and Dukes’ stage at diagnosis were obtained from cancer registry data.
Deprivation category was based on the Index of Multiple Deprivation,14
derived from the postcode of residence. Self-reported ethnicity was
grouped (white v nonwhite). Long-term conditions (LTCs) other than
cancer were selected from a list used in English health surveys by the
Department of Health (Data Supplement), categorized as follows: no
other, one other, two other, or  three other LTCs or not known (no
response). Self-reported disease status was categorized as either remission
or other (recurrent, nontreatable disease, or uncertain about disease sta-
tus). The questionnaire asked about treatment (any surgery, radiotherapy,
or chemotherapy), stoma status (present, reversed, or never formed), and
current employment status (employed, unemployed [with subcategories
of seeking work or unable to work for health reasons], retired, or other or
not known), living arrangements (living with partner, spouse, family, or
friends, living alone, or other or not known), and carer responsibilities
(looking after family, friend, or neighbor because of long-term health
problems or old age [yes v no]).
The SDI-21 is a 21-item questionnaire with the following response cate-
gories: no difficulty (rated 0), a little difficulty (rated 1), quite a bit of difficulty
(rated 2), verymuch difficulty (rated 3), does not apply (rated 0; Data Supple-
ment).9 Sixteenof the items formameasureof social distress (SD),witha score
range (following Rasch-adjusted scoring on four items) of 0 to 44 (SD-16
scale)15 and comprising three subscales: everyday living, money matters, and
self and others (Fig 1).16 A validated cut point of  10 on the SD-16 scale
indicates SD warranting follow-up up by health or social care staff17; this was
used in our analyses as a binary cut point (not socially distressed v socially
distressed). Subscale group cut points for the purpose of this work were
estimated based on the number of items in each subscale, using observations
from the original Rasch analysis, in which items from the money matters
subscale were hardest to endorse and those from the everyday living subscale
easiest to endorse,15 and examining clinically meaningful subscale differences
from earlier work.16 This resulted in estimated cut points of 5 for the everyday
living subscale, 2 for the money matters subscale, and 3 for the self and
others subscale.
TheSDI-21also includesfive single items.These indicatedifficultieswith
the following: sexual matters, plans to have a family, where you live, plans to
travel or take a holiday, and any other difficulty.
SDI-21 items: difficulties with… Subscales /single items Social distress
Everyday living
Score range
0-16 (estimated
cut point 5)
Money matters
Score range 0-13
(estimated cut point 2)
SD-16 Score
range 0-44
(cut point 10)
Self and others 
Score range 0-15
(estimated cut point 3)
Single items
Scored 0,1,2,3
 1 Independence
 2 Domestic chores
 3 Personal care*
 4 Care of dependents*
 17 Getting around
 19 Recreation
 6 Welfare benefits
 7 Finances
 8 Financial services*
 9 Work*
 10 Planning the future
 5 Support for those close to you
 11 Communicating with those close
 12 Communicating with others
 15 Body image
 16 Isolation
 13 Sexual matters
 14 Plans to have a family
 18 Where you live
 20 Holidays
 21 Other
Fig 1. Social Difficulties Inventory (SDI)
scoring guidance. SD, social distress. (*)
Adjusted scoring derived from Rasch anal-
ysis (0,1,2,2).
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Statistical Analysis
Descriptive statistics compared thosewhocompleted theSD-16measure
and those who did not, as well as responses across the SD scale, subscales, and
five single items. 2 tests compared categorical variables. Variables were en-
tered into logistic regressionmodels based on their a priori clinical and public
health importance.Where variableswere highly correlated (eg, tumor site and
stoma status), only one was included in multivariable analyses (based on
clinical interpretation). Statistical significance was set at 1%. Analyses were
performedusingSTATAsoftware (version13.1; STATA,College Station,TX).
RESULTS
Response Rates
The response rate was 63.3% (21,802 of 34,467). The elderly,
those from ethnicminorities, and those living inmore deprived areas
were less likely to participate (all P .001). Of the 21,802 responders,
16,962 (77.8%) completed all SDI-21 items, and17,830 (81.8%) com-
pleted the questionsmaking up the SD-16measure. Completion rates
for the five single items were as follows: sexual matters, 17,504
(80.3%);plans tohavea family, 17,550(80.5%);whereyou live, 17,784
(81.6%); plans to travel or take a holiday, 17,750 (81.4%); and any
other difficulty, 17,588 (80.7%). Women (P  .001), older patients
(P .001), those living inmore deprived areas (P .001), and those
from ethnic minority groups (P .024) were less likely to fully com-
plete the SD-16.
Characteristics of the Population
Table 1 lists the characteristics of the SD-16 respondents. There
weremoremen than women (60.1% v 39.9%), reflecting the propor-
tion of men (57%) and women (43%) surveyed. Amajority were age
 65 years, with 36.2% age  65 years. Approximately one quarter
lived in the least deprived areas, comparedwith11%living in themost
deprived areas.Only 2.0%of respondents came fromnonwhite ethnic
groups. LTCs were common, with only 22.9% of respondents stating
they had no LTCs, and 46.6% reporting two.
When split by tumor site, 61.9% had colon tumors, 7.0% rec-
tosigmoid tumors, and 31.1% rectal tumors. A majority had under-
gone surgery (93.2%), with 19.8% receiving radiotherapy and 48.6%
receiving chemotherapy. One fifth (20.0%) had a stoma present, with
Table 1. Characteristics of Survey Respondents
Characteristic
All Respondents
(N  21,802)
SD-16
Respondents
(n  17,830)
No. % No. %
Sex
Male 12,683 58.2 10,715 60.1
Female 9,119 41.8 7,115 39.9
Age, years
 55 2,040 9.4 1,860 10.4
55-64 5,154 23.6 4,602 25.8
65-74 7,824 35.9 6,428 36.1
75-84 5,633 25.8 4,151 23.3
 85 1,151 5.3 789 4.4
Index of Multiple Deprivation
1 (least deprived) 5,484 25.2 4,682 26.3
2 5,360 24.6 4,435 24.9
3 4,742 21.8 3,858 21.6
4 3,658 16.8 2,894 16.2
5 (most deprived) 2,558 11.7 1,961 11.0
Race/ethnicity
White 20,758 95.2 17,084 95.8
Nonwhite 454 2.1 355 2.0
Not known 590 2.7 391 2.2
Dukes’ disease stage at diagnosis
A 3,533 16.2 2,938 16.5
B 7,376 33.8 5,921 33.2
C 7,638 35.0 6,280 35.2
D 1,379 6.3 1,137 6.4
Not known 1,876 8.6 1,554 8.7
No. of LTCs
None 4,651 21.3 4,090 22.9
1 6,476 29.7 5,414 30.4
2 4,523 20.7 3,645 20.4
 3 4,981 22.8 3,858 21.6
No response 1,171 5.4 823 4.6
Tumor site
Colon 13,577 62.3 11,031 61.9
Rectosigmoid 1,512 6.9 1,252 7.0
Rectum 6,713 30.8 5,547 31.1
Treatment
Surgery
No 1,702 7.8 1,212 6.8
Yes 20,100 92.2 16,618 93.2
Radiotherapy
No 17,502 80.3 14,300 80.2
Yes 4,300 19.7 3,530 19.8
Chemotherapy
No 11,599 53.2 9,160 51.4
Yes 10,203 46.8 8,670 48.6
Stoma status
No stoma 11,821 54.2 9,949 55.8
Reversed 3,378 15.5 2,891 16.2
Present 4,487 20.6 3,571 20.0
No response 2,116 9.7 1,419 8.0
Disease status
Remission 16,642 76.3 14,067 78.9
Other or not known 5,160 23.7 3,763 21.1
Current employment status
Employed 3,493 16.0 3,205 18.0
Unemployed 936 4.3 792 4.4
(continued in next column)
Table 1. Characteristics of Survey Respondents (continued)
Characteristic
All Respondents
(N  21,802)
SD-16
Respondents
(n  17,830)
No. % No. %
Retired 15,314 70.2 12,443 69.8
Other or not known 2,059 9.4 1,390 7.8
Current living arrangements
Live with spouse or family 14,297 65.6 12,182 68.3
Live alone 4,709 21.6 3,646 20.5
Other or not known 2,796 12.8 2,002 11.2
Current carer status
No 17,339 79.5 14,156 79.4
Yes 4,463 20.5 3,674 20.6
Total 21,802 100.0 17,830 100.0
Abbreviations: LTC, long-term condition; SD, social distress.
Social Distress 12 to 36 Months After Colorectal Cancer
www.jco.org © 2015 by American Society of Clinical Oncology 3425
128.243.195.49
Information downloaded from jco.ascopubs.org and provided by at UNIVERSITY NOTTINGHAM on August 1, 2016 from
Copyright © 2015 American Society of Clinical Oncology. All rights reserved.
16.2%reporting a stoma reversal. Some78.9%of individuals reported
they were in remission.
A majority were retired (69.8%); 18.0% were employed either
full- or part-time; 4.4% were unemployed, of whom 616 (77.8%) of
792 were unable to work for health reasons, with the others actively
seekingwork; and7.8%were in theotherornotknowngroup.Among
those ofworking age ( 65 years), 42.4%were employed, 11.7%were
unemployed (actively seeking work, 2.5%; unable to work, 9.2%),
35.1%were retired, and 10.8%were in the other or not known group.
Some 68.3% reported living with a partner, spouse, or family; 20.5%
reported living alone; and 11.2% had other living arrangements (eg,
nursing home) or did not respond. One fifth (20.6%) stated they had
carer responsibilities.
SD-16
Overall, 2,688 (15.1%) of 17,830 respondents were classed as
socially distressed (score  10; Table 2); no differences in sex were
observed.High levels of distress were found in the youngest (age 55
years; 29.0%)andoldest respondents (85years; 20.7%), those living
in the most deprived areas (23.4%), nonwhite respondents (29.3%),
those with advanced disease (Dukes’ stage D; 24.5%), and those with
 three other LTCs (27.2%).
LevelsofSDwerehigher inrespondentswithrectal cancer than in
those with colon or rectosigmoid cancer (18.0%, 13.7%, and 14.8%,
respectively) and in those reporting having a stoma (26.2% v 11.7%
[no stoma] and 13.3% [reversed stoma]). Stomas are used mainly in
treatment of rectal cancer (73.6% of patients with rectal cancer had
stoma at some point v 16.7% of those with colon cancer). Of respon-
dents with rectal cancer, 25.3% of those with a stomawere experienc-
ing SD, compared with 12.3% of those who never had a stoma and
12.2%of thosewith a reversal.High levels of distress were reported by
respondents after radiotherapy (23.0%) and by those with recurrent
or nontreatable disease (29.3%).
Respondents unemployed at the time of the survey had high
levels of SD (56.8%). However, the proportion of socially distressed
respondents who were actively seeking work was lower (29.0%) than
the proportion of those unable to work because of health reasons
(64.8%). There was little difference in distress according to living
arrangements. Respondents who reported being a carer had higher
levels of SD (17.3%) than those who were not a carer (14.5%).
Multivariable analysis showed having  three other LTCs was
the strongest predictor of social distress (odds ratio [OR], 6.64; 95%
Table 2. Proportion of Respondents Scoring  10 on SD-16 Measure
by Characteristic
Characteristic
SD No SD
PNo. % No. %
Sex .597
Male 1,603 15.0 9,112 85.0
Female 1,085 15.2 6,030 84.8
Age, years  .001
 55 540 29.0 1,320 71.0
55-64 761 16.5 3,841 83.5
65-74 690 10.7 5,738 89.3
75-84 534 12.9 3,617 87.1
 85 163 20.7 626 79.3
Index of Multiple Deprivation  .001
1 (least deprived) 535 11.4 4,147 88.6
2 570 12.9 3,865 87.1
3 595 15.4 3,263 84.6
4 530 18.3 2,364 81.7
5 (most deprived) 458 23.4 1,503 76.6
Race/ethnicity  .001
White 2,498 14.6 14,586 85.4
Nonwhite 104 29.3 251 70.7
Not known 86 22.0 305 78.0
Dukes’ disease stage at diagnosis  .001
A 304 10.3 2,634 89.7
B 807 13.6 5,114 86.4
C 1,025 16.3 5,255 83.7
D 278 24.5 859 75.5
Not known 274 17.6 1,280 82.4
No. of LTCs  .001
None 353 8.6 3,737 91.4
1 623 11.5 4,791 88.5
2 521 14.3 3,124 85.7
 3 1,050 27.2 2,808 72.8
No response 141 17.1 682 82.9
Tumor site  .001
Colon 1,506 13.7 9,525 86.3
Rectosigmoid 185 14.8 1,067 85.2
Rectum 997 18.0 4,550 82.0
Treatment
Surgery  .001
No 233 19.2 979 80.8
Yes 2,455 14.8 14,163 85.2
Radiotherapy  .001
No 1,876 13.1 12,424 86.9
Yes 812 23.0 2,718 77.0
Chemotherapy  .001
No 1,167 12.7 7,993 87.3
Yes 1,521 17.5 7,149 82.5
Stoma status  .001
No stoma 1,167 11.7 8,782 88.3
Reversed 384 13.3 2,507 86.7
Present 937 26.2 2,634 73.8
No response 200 14.1 1,219 85.9
Disease status  .001
Remission 1,587 11.3 12,480 88.7
Other or not known 1,101 29.3 2,662 70.7
Current employment status  .001
Employed 426 13.3 2,779 86.7
Unemployed 450 56.8 342 43.2
Retired 1,546 12.4 10,897 87.6
Other or not known 266 19.1 1,124 80.9
(continued in next column)
Table 2. Proportion of Respondents Scoring  10 on SD-16 Measure
by Characteristic (continued)
Characteristic
SD No SD
PNo. % No. %
Current living arrangements .031
Live with spouse or family 1,778 14.6 10,404 85.4
Live alone 590 16.2 3,056 83.8
Other or not known 320 16.0 1,682 84.0
Current carer status  .001
No 2,053 14.5 12,103 85.5
Yes 635 17.3 3,039 82.7
Total 2,688 15.1 15,142 84.9
Abbreviations: LTC, long-term condition; SD, social distress.
Indicating SD.
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CI, 5.67 to 7.77 vnoLTCs), followed by being unemployed (OR, 5.11;
95% CI, 4.21 to 6.20 v employed), having recurrent or nontreatable
disease (OR, 2.75; 95% CI, 2.49 to 3.04 v remission), and having a
stoma (OR, 2.10; 95%CI, 1.86 to 2.36 v never had stoma). Younger
age, living in a more deprived area, being nonwhite, having more
advanced disease at diagnosis, having undergone radiotherapy,
and being a carer were also significant predictors of SD (Table 3
lists all ORs).
SDI Subscales
Regarding the separate subscales, 19.5% of respondents had dif-
ficulties with everyday living (score 5), 15.6% had difficulties with
money matters (score 2), and 18.1% had difficulties with self and
others (score 3). Multivariable analysis demonstrated presence of
other LTCs was a strong predictor of difficulties on all three subscales
but was strongest on the everyday living subscale (OR, 7.37; 95% CI,
6.36 to 8.55 for three LTCs vnone).Unemploymentwas an impor-
tant predictor on all three subscales but strongest on the everyday
living subscale (OR, 6.02; 95% CI, 4.91 to 7.38 v employed group).
Older age ( 85 years) was predictive of problems on the everyday
living subscale but had a protective effect on the other two subscales.
Having carer responsibilitieswas an importantpredictorofdistress on
the money matters and self and others subscales. Women were less
likely to have difficulties with money matters but were more likely
to have problems on the self and others subscale. Chemotherapy
affected the money matters subscale but not the other subscales
(Table 4 lists all ORs).
SDI Single Items
Only 0.7%reporteddifficultieswith plans to have a family. Some
2.9%of respondents reported difficulties with where they lived. Diffi-
culties with travel or taking a holiday were reported by 17.5% of
respondents; this was higher in those with a stoma (34.6%) than in
thosewith a reversed stoma (19.7%)orno stoma (13.2%;P .001).A
further 8.4% reported difficulties in any other aspect of life. Detailed
analysis of the question concerning sexual matters has been reported
elsewhere.10 Overall, 16.0% reported difficulties with sexual matters
(answered quite a bit or very much).
DISCUSSION
To our knowledge, this is the largest investigation of social outcomes
inpatientswithCRCand,webelieve, inpatientswithanycancer in the
early years of survival. Most patients with CRC showed considerable
resilience 1 to 3 years postdiagnosis. However, a sizable minority
(15%) reported significant SD.Our results demonstrate this is related
not only to the CRC diagnosis and treatment but also to additional,
readily identifiable clinical and social factors. These factors may or
may not be independent of the cancer and cancer treatment (eg,
unemployment). When these factors are present and potentially
working in combination, they put people at greater risk of SD.
Thestudydesignresulted ina largeunselectedall-comers sample,
withgooddataquality andcompleteness.The63%response rate is the
same as that reported in a recent survey of supportive care of patients
with CRC, in which a similar approach was used (no exclusion crite-
ria).18 The identification of individuals via the NCRS eliminated hos-
pital or clinical trial selection bias, a limitation of many reported
Table 3. Logistic Regression Model for SD-16 (n  17,830)
Variable OR 95% CI P
Sex .082
Male 1.00
Female 1.09 0.99 to 1.20
Age, years  .001
 55 1.00
55-64 0.42 0.36 to 0.50
65-74 0.26 0.22 to 0.32
75-84 0.26 0.21 to 0.32
 85 0.41 0.31 to 0.53
Index of Multiple Deprivation  .001
1 (least deprived) 1.00
2 1.07 0.93 to 1.23
3 1.21 1.06 to 1.39
4 1.29 1.12 to 1.49
5 (most deprived) 1.45 1.24 to 1.70
Race/ethnicity  .001
White 1.00
Nonwhite 1.70 1.30 to 2.22
No response 1.55 1.17 to 2.03
Dukes’ disease stage at diagnosis  .001
A 1.00
B 1.41 1.21 to 1.64
C 1.41 1.19 to 1.66
D 1.69 1.36 to 2.10
Not known 1.25 1.02 to 1.53
No. of LTCs  .001
None 1.00
1 1.76 1.51 to 2.05
2 2.69 2.29 to 3.16
 3 6.64 5.67 to 7.77
No response 1.99 1.57 to 2.52
Treatment
Radiotherapy  .001
No 1.00
Yes 1.34 1.18 to 1.51
Chemotherapy .295
No 1.00
Yes 1.07 0.95 to 1.20
Stoma status  .001
No stoma 1.00
Reversed 1.14 0.99 to 1.31
Present 2.10 1.86 to 2.36
No response 1.02 0.85 to 1.22
Disease status  .001
Remission 1.00
Other or not known 2.75 2.49 to 3.04
Current employment status  .001
Employed 1.00
Unemployed 5.11 4.21 to 6.20
Retired 1.04 0.88 to 1.23
Other or not known 1.52 1.25 to 1.84
Current living arrangements .969
Live with spouse or family 1.00
Live alone 1.01 0.89 to 1.13
Other or not known 1.02 0.88 to 1.18
Current carer status  .001
No 1.00
Yes 1.30 1.16 to 1.45
NOTE. Adjusted for all other variables in table. Because of correlations
between some variables, tumor site and surgery were omitted from multivari-
able analyses.
Abbreviations: LTC, long-term condition; OR, odds ratio; SD, social distress.
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Table 4. Logistic Regression Models for Subscales (n  17,830)
Variable
Everyday Living Money Matters Self and Others
OR 95% CI P OR 95% CI P OR 95% CI P
Sex .003  .001  .001
Male 1.00 1.00 1.00
Female 1.15 1.05 to 1.25 0.66 0.60 to 0.73 1.31 1.20 to 1.43
Age, years  .001  .001  .001
 55 1.00 1.00 1.00
55-64 0.58 0.49 to 0.69 0.46 0.40 to 0.53 0.40 0.35 to 0.46
65-74 0.50 0.41 to 0.61 0.22 0.18 to 0.26 0.21 0.18 to 0.25
75-84 0.69 0.56 to 0.85 0.16 0.13 to 0.19 0.15 0.13 to 0.19
 85 1.45 1.13 to 1.88 0.12 0.08 to 0.17 0.18 0.14 to 0.23
Index of Multiple Deprivation  .001  .001 .004
1 (least deprived) 1.00 1.00 1.00
2 1.03 0.91 to 1.16 1.18 1.04 to 1.35 1.20 1.06 to 1.35
3 1.16 1.03 to 1.32 1.25 1.09 to 1.43 1.21 1.07 to 1.37
4 1.31 1.14 to 1.49 1.40 1.22 to 1.62 1.26 1.10 to 1.43
5 (most deprived) 1.43 1.23 to 1.65 1.39 1.18 to 1.63 1.22 1.05 to 1.42
Race/ethnicity  .001  .001 .396
White 1.00 1.00 1.00
Nonwhite 1.68 1.29 to 2.19 2.49 1.93 to 3.21 1.11 0.85 to 1.45
No response 1.37 1.05 to 1.78 1.63 1.25 to 2.14 1.17 0.90 to 1.54
Dukes’ disease stage at diagnosis  .001 .05 .006
A 1.00 1.00 1.00
B 1.38 1.20 to 1.59 1.22 1.05 to 1.42 1.21 1.05 to 1.39
C 1.43 1.23 to 1.67 1.22 1.03 to 1.43 1.29 1.11 to 1.49
D 1.89 1.55 to 2.32 1.22 0.98 to 1.53 1.40 1.15 to 1.71
Not known 1.28 1.06 to 1.54 1.04 0.85 to 1.28 1.29 1.08 to 1.55
No. of LTCs  .001  .001  .001
None 1.00 1.00 1.00
1 1.71 1.48 to 1.99 1.45 1.27 to 1.66 1.50 1.32 to 1.70
2 2.90 2.48 to 3.38 1.99 1.72 to 2.31 2.00 1.74 to 2.30
 3 7.37 6.36 to 8.55 3.32 2.86 to 3.86 4.26 3.71 to 4.89
No response 1.92 1.51 to 2.43 1.64 1.32 to 2.03 1.59 1.29 to 1.97
Treatment
Radiotherapy
No 1.00  .001 1.00 .116 1.00 .002
Yes 1.31 1.16 to 1.47 1.10 0.98 to 1.25 1.20 1.07 to 1.34
Chemotherapy
No 1.00 .213 1.00  .001 1.00 .289
Yes 1.07 0.96 to 1.20 1.35 1.20 to 1.52 1.06 0.95 to 1.18
Stoma status
No stoma 1.00  .001 1.00  .001 1.00  .001
Reversed 1.08 0.95 to 1.24 1.31 1.15 to 1.49 1.25 1.10 to 1.42
Present 2.15 1.92 to 2.40 1.57 1.39 to 1.78 2.30 2.05 to 2.57
No response 1.09 0.93 to 1.28 1.02 0.85 to 1.22 1.17 1.00 to 1.38
Disease status
Remission 1.00  .001 1.00  .001 1.00  .001
Other or not known 2.76 2.51 to 3.03 1.82 1.63 to 2.03 2.20 2.00 to 2.42
Current employment
Employed 1.00  .001 1.00  .001 1.00  .001
Unemployed 6.02 4.91 to 7.38 3.58 2.98 to 4.29 2.37 1.98 to 2.83
Retired 1.75 1.47 to 2.09 0.50 0.44 to 0.58 0.95 0.82 to 1.09
Other or not known 2.22 1.81 to 2.72 1.01 0.85 to 1.20 1.21 1.02 to 1.44
Current living arrangements
Live with spouse or family 1.00 .789 1.00  .001 1.00 .022
Live alone 0.96 0.86 to 1.07 1.28 1.13 to 1.44 1.15 1.03 to 1.28
Other or not known 1.00 0.87 to 1.15 1.15 0.99 to 1.32 1.13 0.98 to 1.29
Current carer status
No 1.00 .009 1.00  .001 1.00  .001
Yes 1.15 1.04 to 1.27 1.50 1.35 to 1.68 1.50 1.36 to 1.66
NOTE. Adjusted for all other variables in table. Because of correlations between some variables, Dukes’ stage, tumor site, and surgery were omitted from
multivariable analyses.
Abbreviations: LTC, long-term condition; OR, odds ratio.
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outcomestudies. Encouragingly,mostparticipantswerebelow the cut
point forSD, similar tofindings fromaDutchstudyexploring living in
good health after treatment for CRC.6 However, 15% of respondents
reported high SD-16 scores, with an impact across all subscales. The
highest levels of SD and subscale distress were seen in patients report-
ing multimorbidity, not being in remission, having a stoma present,
and being unemployed. The cumulative effect of morbidity, with two
otherLTCsplus cancerbeingworse thanoneotherLTCplus cancer, is
consistent with that seen in previous studies.19 Although only 4.4%of
the sample was unemployed, more than half of participants were
socially distressed and not only were at risk of experiencing severe
money matters difficulties but also faced problems in the other sub-
scales, especially everyday living, in comparison with employed par-
ticipants.Thismaybe accounted for inpart by the respondentsunable
toundertakepaidwork forhealth reasons,possibly cancer related, and
also by those struggling with household chores for similar reasons.
Thisdemonstrates the additional burden facedbypatientswith cancer
who cannot find or are unable to work and reinforces the need to
provide vocational rehabilitation services.20 Age, ethnicity, socioeco-
nomic deprivation, being diagnosed with more advanced disease,
undergoing radiotherapy, and having caring responsibilities also af-
fected levels of SD.There is literature on carers of patientswith cancer,
but less is known about patients with cancer who are carers them-
selves. As the population ages, mutual caring will become common-
place andwill need to be addressed.21 Differences in sexwere not seen
in overall SD-16 scores, but subscale examination revealed men had
more problems with money matters and women with self and others
and, to a lesser extent, everyday living subscales, suggesting some
traditional gender roles continue to prevail.
The study is limited by the lack of amatched case-control group,
baseline data, and general population normative data. Although
population-based samplingwasused, another limitation is differences
in participant and nonparticipant characteristics. However, the large
scale of this study, with a response rate of 63%, where almost 18,000
participantshad fully complete SD-16data, has resulted in someof the
best evidence to date. The validity of the self-reported disease status
data is untested, but, reassuringly, high concordance has been re-
ported between self-report by patients with breast cancer andmedical
records data.22
With cost-limited health and social care services and greater
reliance on informal carers and the voluntary sector, new ways of
providing appropriate, cost-effective, and timely support for CRC
survivors who need it must be found. The primary focus of CRC
clinical follow-up care remains detection of recurrence. Guidance in
the United Kingdom recommends follow-up be discontinued when
thepatient andhealth careprofessionalhavediscussedandagreed that
likely benefits no longer outweigh the risks of additional tests.23 Al-
though there are national guidelines for incorporating assessment of
and support for the social impact of cancer,24-26 their implementation
is patchy. Only 27% of individuals diagnosed with CRC or lower GI
cancer reportedbeingoffered awritten assessment (includingpsycho-
social assessment) or care plan.27 An obvious time for undertaking
assessment would be on completion of primary treatment. On the
basisof the survey results, one in sixpatients is likely tobeexperiencing
SD. However, to allow for response bias, with the characteristics of
nonparticipants likely being associated significantly with SD (older
age,minority ethnicity, andmore deprivation), and for thosewhodid
not survive long enough to be surveyed, the prevalence of SD in
patients with CRC overall may be higher.
Some cancer services routinely perform risk-based screening of
patients with the SDI-21 using touchscreen technology, which pro-
vides an efficient and effective way to identify patients with prob-
lems.28 However, where access to electronic systems is limited, a
simple checklist derived from the identified factors associated with
development of SD could be used to identify patients in high-risk
groups. This would ensure the sizeable minority (2,688 of 18,830 in
this cohort) at risk of experiencing SD can be targeted by appropriate
health and social care staff.29 Primary care follow-up has been shown
to be satisfactory formany patients withCRC, but for those identified
asbeingatgreater riskofpooreroutcomes,multiple-provider care (eg,
primary, secondary, social) may be more appropriate.30 Although in
the critical early years postdiagnosis, when recurrence ismost likely to
occur, theCRCteammustplay aprimary role, generalistswith a remit
to care for people with multiple LTCs (eg, general practitioners,
nurses, caremanagers, or geriatricians)may be best placed to support
disease-free CRC survivors with complex problems.31,32 A model of
supportive care for survivors at completionofprimaryCRCtreatment
might include: assessment with the SDI-21 (or shorter form, if one
could be derived using psychometric approaches) or a simple check-
list, associated care planning, access to up-to-date supportive care
information and services to aid individual self-management, and, for
those with non-CRC complex problems, referral to key generalists.
Theuseofpatient-reportedoutcomemeasures todrive change in
health care organization and delivery has been advocated.33 By assess-
ing patient-reported outcomes, we have defined easily identifiable
cancer- and non–cancer-related factors for the minority who experi-
encehigher levelsof SD.This strongevidencebasemaybedrawnon to
inform change to enable the delivery of robust risk-stratified targeted
support for those at risk of experiencing poor social outcomes.
How outcomes of patients with CRC compare with those
experienced by other cancer survivors, people living with LTCs,
and healthy individuals from the general population is unknown.
Similar surveys of individuals living with and beyond other cancers
should be undertaken, if possible incorporating matched control
groups. Health economic evaluation of the implications of provid-
ing health and social care support for those at highest risk should be
a focus for future research.
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GLOSSARY TERMS
comorbidity: having two or more diseases at the same
time.
health-related quality of life (HRQoL): a broad multi-
dimensional concept that usually includes self-reported measures
of physical and mental health.
patient-reported outcomes: questionnaires used in a clin-
ical setting to systemically collect information directly from the
patient.
psychosocial: the psychological (emotional) and social aspects of a
disease and its treatment. Some of the psychosocial aspects of cancer are
its effects on patients’ feelings, moods, beliefs, the way they cope, and
relationships with family, friends, and coworkers.
risk-basedscreening: screening for long-termand late cancer and cancer
treatment–related effects that considers health risks related to the patient (age at
treatment, attained age, sex, race, genetics, health behaviors, etc) and cancer
(histology; involved sites; specific treatment like surgery, radiation, chemother-
apy, hematopoietic cell transplantation, transfusion, etc).
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